SAVE THE DATE
2024 National Biotechnology Conference
May 13-16, 2024
San Francisco, CA
A tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and new modalities. Submissions are invited on topics related to multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, cells, and allogenic and synthetic cells. Discussions are encouraged on diverse strategies for the discovery, formulation, and delivery of these modalities to address unmet medical needs.
Theme 1: Preformulation and Formulation Approaches for Biologics and New Modalities
Explore the challenges associated with preformulation and formulation development of biologics and new modalities. In addition to the modalities mentioned above under Track 1, submissions related to screening and excipients selection, the impact of excipients on pharmacokinetics/pharmacodynamics (PK/PD), and stability are welcome. Discussions of CMC (Chemistry, Manufacturing, and Controls) issues related to the development of these modalities are encouraged.
Theme 2: Drug Delivery for New Modalities and Therapies
This theme focuses on different strategies and challenges involved in the design of drug delivery systems, the delivery of biologics, and manufacturing challenges in the development of novel drug delivery systems. Topics such as nanoparticles, liposomes, hydrogels, ADCs (Antibody-Drug Conjugates), nano bots and devices, personalized medicines, cell-based therapies, and viral and non-viral gene delivery are the primary focus. Submissions on advances in the delivery of genes, vaccines, and biotherapeutics via non-parenteral routes of administration (e.g., oral, topical, intravitreal, nasal, and inhalation) are encouraged.
Theme 3: AI/ML in Drug Discovery and Development
This track explores how Artificial Intelligence/Machine Learning (AI/ML) and big data are transforming the landscape of drug development and reducing discovery time and cost. Submissions are welcome on novel biotherapeutics developed using AI; AI-enabled gene-editing drugs; and the combination of AI, synthetic biology, and cell manufacturing as well as their impact on new drugs, novel design, and manufacturing processes. Topics to be covered include: CMC and regulatory issues; the use of AI in CMC and process development; decentralized manufacturing, risks, and benefits associated with using AI in drug discovery and development; and data integrity concerns.
View the entire 2024 program online!
Call for Papers
AAPS is now accepting abstract submissions for poster presentation at the 2024 AAPS National Biotechnology Conference. Review the Tracks and Themes in the Call for Poster Abstracts. Abstracts must relate to one of this year’s Tracks. The Submission Deadline is January 24, 2024 at 5pm ET.
Submit Today!
SAVE THE DATE
2024 Summer Scientific Forum
July 22-25, 2024
Kansas City, MO